dromlakhani/md2skill/endo-ace-arb-ccb-htn

Claude Code and agent skill by dromlakhani/md2skill

Trust tier 3
  • community
Source check pending

Checking that the SKILL.md file is still in the repository.

Recommends ACE inhibitors, ARBs, or calcium channel blockers as first-line hypertension therapy rather than β‑adrenergic blockers in obese patients with type 2 diabetes. Triggers include when a clinician asks, 'What antihypertensive should I start for this obese patient with T2DM to avoid weight gain?' or 'Should I avoid β‑blockers in this patient with diabetes and hypertension?'

Install

npx vskill@latest install dromlakhani/md2skill/endo-ace-arb-ccb-htn

SKILL.md

The same SKILL.md was published earlier as majiayu000/claude-skill-registry-data/endo-ace-arb-ccb-htn.

Prefer ACE/ARB/CCB over β‑blockers for hypertension in T2DM obese

STEP 1 — Gather Information

Confirm diagnosis of type 2 diabetes, obesity (BMI ≥ 30 kg/m² or BMI ≥ 27 kg/m² with comorbidity), and presence of hypertension; assess for contraindications to ACEI/ARB/CCB (pregnancy, bilateral renal artery stenosis, hyperkalemia, angioedema history) and for compelling β‑blocker indications (HFrEF, post‑MI, angina).

STEP 2 — Rule In / Rule Out

If a compelling β‑blocker indication exists (e.g., HFrEF, recent MI), consider β‑blocker; otherwise, rule out β‑blocker as first‑line and proceed to ACE/ARB/CCB selection.

STEP 3 — Classify or Stratify

Choose agent based on comorbidities: ACEI or ARB preferred if albuminuria, CKD, or heart failure with preserved EF; CCB preferred if edema risk is low and patient needs avoidance of cough/hyperkalemia; avoid ACEI/ARB in pregnancy or bilateral stenosis.

STEP 4 — Decide

Initiate the selected ACEI, ARB, or CCB at low dose, titrate to target BP; document avoidance of β‑blocker unless a compelling indication arises later.

Clinical Guardrails / Mimics / Pitfalls

Do not use β‑blockers solely for hypertension in obese T2DM due to risk of weight gain, worsened insulin resistance, and masking hypoglycemia symptoms; avoid non‑selective β‑blockers without vasodilating properties; do not combine ACEI and ARB; monitor for ACEI‑related cough or angioedema, ARB‑related hyperkalemia, and CCB‑related peripheral edema.

Concrete Clinical Example

A 58‑year‑old woman with T2DM, BMI 34 kg/m², BP 152/96 mmHg, no heart failure or post‑MI, is started on lisinopril 10 mg daily after confirming no contraindications; β‑blocker is avoided to limit weight gain and insulin resistance.

Source: Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2014-3415

Security

  • Security scanPassed, 90 of 100Pattern checks on the skill's files.
  • Model reviewPassed

Quality evaluation

  • Task evaluationNot runNo evaluation yet. Run one in Skill Studio.

Source

Popularity

Repository stars
12
Repository forks
1
7-day trend score
18

Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.

Works with

Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.

  • Claude Code
  • Cursor
  • GitHub Copilot
  • Windsurf
  • Codex
  • Gemini CLI
  • Cline
  • Amp
  • Roo Code
  • Goose
  • Continue
  • Kilo Code
  • Junie
  • Trae
  • OpenHands
  • Qwen Code
  • AI Agent
  • Tabnine Chat
  • Sourcegraph Cody
  • Amazon Q
  • Firebase Genkit
  • Sweep
  • Devin
  • Phind
  • Mentat
  • Claude Desktop
  • Aider
  • GPT Pilot
  • Plandex
  • bolt.new
  • v0
  • Replit Agent
  • Anse
  • TypingMind
  • BetterChatGPT
  • LibreChat
  • Warp AI
  • Pieces
  • Fig AI
Embed badge
vskill VERIFIED badge
[![vskill VERIFIED](https://verified-skill.com/api/v1/skills/dromlakhani/md2skill/endo-ace-arb-ccb-htn/badge)](https://verified-skill.com/skills/dromlakhani/md2skill/endo-ace-arb-ccb-htn)

Something wrong with this skill or its page? Tell us.